Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated April 1, 2022, with respect to the consolidated financial statements of Senti Biosciences, Inc. and subsidiary, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
June 28, 2022
